Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,157,271
+$819,436 QoQ
Shares Held
2,735,970
-4.2% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 84.05899918493259.ToString("F0")%
Shared 0.ToString("F0")%
None 15.941000815067415.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. ANNX ranks #110 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,157,271 | 2,735,970 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,337,835 | 2,856,143 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,241,034 | 3,029,848 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,998,093 | 832,540 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,353,613 | 701,356 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,307,190 | 644,677 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,314,067 | 1,235,485 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,941,226 | 1,008,414 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,449,503 | 899,513 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $871,950 | 192,060 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $351,853 | 149,092 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $377,824 | 107,337 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $531,698 | 138,104 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $439,297 | 84,971 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $339,558 | 54,945 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $422,821 | 112,155 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $732,516 | 268,322 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,450,409 | 300,297 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $979,255 | 52,620 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,175,679 | 96,654 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $972,868 | 34,945 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,044,251 | 41,720 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $75,363 | 2,493 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||